Connection

Patrick O'Neil to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Patrick O'Neil has written about Treatment Outcome.
Patrick O'Neil
Connection Strength
0.322
Treatment Outcome
  1. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.
    View in: PubMed
    Score: 0.068
  2. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
    View in: PubMed
    Score: 0.049
  3. Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
    View in: PubMed
    Score: 0.049
  4. Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eat Behav. 2012 Dec; 13(4):354-60.
    View in: PubMed
    Score: 0.045
  5. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.
    View in: PubMed
    Score: 0.022
  6. Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.
    View in: PubMed
    Score: 0.015
  7. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016 09; 40(9):1369-75.
    View in: PubMed
    Score: 0.015
  8. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013 Nov; 21(11):2189-2196.
    View in: PubMed
    Score: 0.012
  9. The Food Craving Questionnaire-Trait in a bariatric surgery seeking population and ability to predict post-surgery weight loss at six months. Eat Behav. 2012 Dec; 13(4):366-70.
    View in: PubMed
    Score: 0.011
  10. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
    View in: PubMed
    Score: 0.010
  11. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance. Am J Drug Alcohol Abuse. 2007; 33(5):655-64.
    View in: PubMed
    Score: 0.008
  12. Smoking status and weight loss in three weight loss programs. Eat Behav. 2006 Jan; 7(1):61-8.
    View in: PubMed
    Score: 0.007
  13. Cognitive appraisals of dietary transgressions by obese women: associations with self-reported eating behavior, depression, and actual weight loss. Int J Obes Relat Metab Disord. 1999 Mar; 23(3):231-7.
    View in: PubMed
    Score: 0.004
  14. Clinical trial design for obesity agents: a workshop report. Obes Res. 1998 Jul; 6(4):311-5.
    View in: PubMed
    Score: 0.004
  15. Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 1997 Dec; 67(3):272-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.